(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202209 | 202109 | % Var | 202209 | 202109 | % Var | 202203 | 202103 | % Var | |
| Sales | 52852.90 | 41431.50 | 27.57 | 102181.70 | 78084.40 | 30.86 | 155859.80 | 141160.50 | 10.41 |
| Other Income | 417.10 | 2842.70 | -85.33 | 2179.20 | 4959.60 | -56.06 | 11968.80 | 1920.70 | 523.15 |
| PBIDT | 17048.80 | 11485.40 | 48.44 | 32035.30 | 16035.70 | 99.77 | 38654.40 | 24490.80 | 57.83 |
| Interest | 927.70 | 1039.80 | -10.78 | 1798.40 | 2114.40 | -14.95 | 3881.00 | 2675.20 | 45.07 |
| PBDT | 16121.10 | 10445.60 | 54.33 | 30236.90 | 12265.60 | 146.52 | 16568.10 | 20920.00 | -20.80 |
| Depreciation | 3839.50 | 3336.40 | 15.08 | 7584.50 | 6405.70 | 18.40 | 13499.50 | 12364.30 | 9.18 |
| PBT | 12281.60 | 7109.20 | 72.76 | 22652.40 | 5859.90 | 286.57 | 3068.60 | 8555.70 | -64.13 |
| TAX | 151.50 | -981.50 | -115.44 | 404.30 | -848.00 | -147.68 | 4068.50 | 131.70 | 2989.22 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 12130.10 | 8090.70 | 49.93 | 22248.10 | 6707.90 | 231.67 | -999.90 | 8424.00 | -111.87 |
| Equity | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 |
| PBIDTM(%) | 32.26 | 27.72 | 16.36 | 31.35 | 20.54 | 52.66 | 24.80 | 17.35 | 42.95 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: